| Adela Slaton, DDS | |
|
1166 K St, Brawley, CA 92227-2737 | |
| (760) 344-9951 | |
| (760) 344-1620 |
| Full Name | Adela Slaton |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 1166 K St, Brawley, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720342637 | NPI | - | NPPES |
| 44262-02 | Other | CA | DENTI CAL |
| 2504 | Other | CA | DENTAL HEALTH SERVICES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 44262 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Adela Slaton, DDS 1166 K St, Brawley, CA 92227-2737 Ph: (760) 344-9951 | Adela Slaton, DDS 1166 K St, Brawley, CA 92227-2737 Ph: (760) 344-9951 |
News Archive
Using 5α- reductase inhibitors was not associated with increased suicide risk in a group of older men but risks for self-harm and depression were increased during the 18 months after medication initiation, although "the relatively small magnitude of these risks should not dissuade physicians from prescribing these medications in appropriate patients," according to an article published online by JAMA Internal Medicine.
ChemoCentryx, Inc., today announced that it reported positive preclinical and Phase I study results at the European Association for the Study of Diabetes (EASD). CCX140, a novel, orally bioavailable small molecule antagonist of the chemokine receptor CCR2, improved metabolic function while significantly reducing inflammatory macrophages found in adipose tissue in an animal model, and was well tolerated in Phase I clinical trials.
Senomyx, Inc. announced today the pricing of an underwritten public offering of 7,142,857 shares of its common stock at a price to the public of $2.80 per share. The gross proceeds from the sale of the shares, before underwriting discounts and commissions and other offering expenses, are expected to be approximately $20.0 million. The offering is expected to close on or about February 18, 2010, subject to customary closing conditions. Senomyx has also granted the underwriters a 30-day option to purchase up to an aggregate of 1,071,428 additional shares of common stock to cover over-allotments, if any.
We regularly hear reports that laser printers release pathogenic toner dust into the ambient air. How much of it can we believe? What kind of particles do the printers really emit, and in what quantities?
› Verified 8 days ago
Isamel Paul Yturralde, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1166 K St, Brawley, CA 92227 Phone: 760-344-3583 | |
Dr. Ronald C. Stillman, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 580 G St, Brawley, CA 92227 Phone: 760-344-1613 Fax: 760-351-2137 | |
Brian Shue, MD Dentist Medicare: Medicare Enrolled Practice Location: 1166 K St, Brawley, CA 92227 Phone: 760-344-9951 | |
Dr. Amadis J. Lugo, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 229 Main St Ste 101, Brawley, CA 92227 Phone: 760-344-5846 Fax: 760-344-7906 | |
Thomas L Roderick, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1166 K St, Brawley, CA 92227 Phone: 760-344-3583 Fax: 760-344-8480 | |
Dr. Jaime Salas Dominguez, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 1166 K St, Brawley, CA 92227 Phone: 760-344-3583 Fax: 760-344-8480 | |
Mr. Leon R Parrilla, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 114 J St, Brawley, CA 92227 Phone: 760-344-2341 Fax: 760-344-5177 |